Specifications
Immunogen
Recombinant fragment within Human C20orf31 aa 450 to the C-terminus. The exact sequence is proprietary.Database link: Q9BV94
Applications
Application Notes
WB: 1/1000 - 1/10000.
Target
Alternative Names
EDEM2; ER degradation enhancer, mannosidase alpha-like 2; C20orf31, C20orf49, chromosome 20 open reading frame 31; ER degradation-enhancing alpha-mannosidase-like 2; bA4204.1; FLJ10783; ER degradation-enhancing-mannosidase-like protein 2; C20orf31; C20or
Product Background
Antigen Description
Involved in endoplasmic reticulum-associated degradation (ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. It lacks mannosidase activity. Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle.
Pathway
Asparagine N-linked glycosylation, organism-specific biosystem; Calnexin/calreticulin cycle, organism-specific biosystem; ER Quality Control Compartment (ERQC), organism-specific biosystem; Metabolism of proteins, organism-specific biosystem; N-glycan trimming in the ER and Calnexin/Calreticulin cycle, organism-specific biosystem; Post-translational protein modification, organism-specific biosystem; Protein processing in endoplasmic reticulum, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-6854 in a publication?
Let us know and earn a reward for your research.